Green Arrow Capital Management’s Celgene Corp CELG Stock Holding History

Green Arrow Capital Management’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-80,000	Closed	-$6.87M	–	252
2014 Q2	$6.87M	Buy	+80,000	New	+$6.08M	0.86%	31
2014 Q1	–	Sell	-18,000	Closed	-$1.52M	–	354
2013 Q4	$1.52M	Sell	18,000 -32,000	-64%	-$2.53M	0.11%	194
2013 Q3	$3.85M	Buy	+50,000	New	+$3.5M	0.29%	113

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Green Arrow Capital Management's CELG Position: Q3 2014 in Review

Green Arrow Capital Management sold out of Celgene Corp (CELG) in Q3 2014, closing a stake of 80,000 shares — an estimated $6.87M sold.

Green Arrow Capital Management first reported a position in CELG in Q3 2013 and held it in 3 quarters. The position peaked at $6.87M in Q2 2014. 1,031 funds tracked by Wall St. Rank hold CELG as of Q3 2014.

Green Arrow Capital Management reported no remaining Celgene Corp position as of Q3 2014 after selling out during the quarter.
Green Arrow Capital Management sold 80,000 Celgene Corp shares in Q3 2014, an estimated $6.87M.
Green Arrow Capital Management first reported a position in Celgene Corp in Q3 2013 and held it in 3 quarters.
Green Arrow Capital Management's Celgene Corp position peaked at $6.87M in Q2 2014.
1,031 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2014.

Based on Green Arrow Capital Management's 13F filing for Q3 2014, filed 14 Nov 2014.